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a b s t r a c t
The infection of the avian coronavirus infectious bronchitis virus (IBV) is initiated by the binding of the
spike glycoprotein S to sialic acids on the chicken host cell. In this study we identiﬁed the receptor-
binding domain (RBD) of the spike of the prototype IBV strain M41. By analyzing the ability of
recombinantly expressed chimeric and truncated spike proteins to bind to chicken tissues, we
demonstrate that the N-terminal 253 amino acids of the spike are both required and sufﬁcient for
binding to chicken respiratory tract in an α-2,3-sialic acid-dependent manner. Critical amino acids for
attachment of M41 spike are present within the N-terminal residues 19–69, which overlap with a
hypervariable region in the S1 gene. Our results may help to understand the differences between IBV S1
genotypes and the ultimate pathogenesis of IBV in chickens.
& 2013 Elsevier Inc. All rights reserved.
Introduction
Coronaviruses are enveloped, positive-strand RNA viruses of
both human and veterinary importance. They cause a variety of
diseases in many different species, thereby affecting the respiratory,
gastrointestinal, hepatic and central nervous systems (Holmes and
Lai, 1996). Infectious bronchitis virus (IBV) is the prototype avian
coronavirus, belonging to the genus Gammacoronaviridae and is an
economically very important pathogen for poultry. Many different
IBV strains have been reported in chickens worldwide (Jackwood,
2012), with pathology ranging from mild respiratory symptoms to
severe kidney and oviduct disease (Cavanagh, 2007).
Coronavirus binding to and entry into susceptible host cells
requires the interaction between cell surface receptors and the
viral attachment protein spike (S). The S protein is a type I glyco-
protein and contains a signal sequence, ectodomain, transmembrane
domain and endodomain. As for some, but not all, coronaviruses the
spike is cleaved by host proteases (de Haan et al., 2004; Yamada and
Liu, 2009), its ectodomain is further divided into S1 and S2 subunit
or domain. Previous studies indicated that the so-called receptor-
binding domain (RBD) is located in S1, while the S2 subunit or
domain is required for fusion of the virus membrane with that of the
host cell. RBDs are usually regions of several hundred amino acids
that can fold independently and that are sufﬁcient for binding to the
host cell receptor. For a wide variety of coronaviruses the RBD has
been mapped, even for the very recently identiﬁed MERS-CoV (Mou
et al., 2013; Du et al., 2013). They are located in either the N-terminal
(NTD) or the C-terminal (CTD) domain of the S1 protein and are
required for the interaction with either protein receptors or sugars
(reviewed in (Belouzard et al., 2012; Graham and Baric, 2010)).
Despite IBV being the ﬁrst coronavirus ever isolated (Beaudette and
Hudson, 1937), its RBD, including that from the best studied IBV
strain Beaudette, has not yet been mapped. Elucidation of such
critical determinant for binding has partly been hampered by the
lack of cell culture systems for avian coronavirus ﬁeld isolates. In
addition, and in contrast to many other coronaviruses, the protein
receptor for IBV has yet to be elucidated and only alpha-2,3-linked
sialic acids have been shown to be essential for spike attachment
(Wickramasinghe et al., 2011) and subsequent infection of host cells
(Winter et al., 2008; Winter et al., 2006; Abd El Rahman et al., 2009).
Here we aimed at mapping the RBD of the prototype IBV strain
M41. M41 is a virulent respiratory IBV strain, whose S1 protein has
afﬁnity for chicken trachea, while the S1 of the embryo- and cell
culture adapted IBV strain Beaudette has lost its binding capacity
as assessed by spike histochemistry (Wickramasinghe et al., 2011).
In this study, we used these differences to identify the RBD of M41
and to elucidate amino acids that are critical for the interaction
with host tissues. Our data show that the NTD of S1 (aa 19–272,
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most N-terminal 253 aa of the mature S1) is both required and
sufﬁcient for binding to the respiratory tract. In particular, amino
acids N38, H43, P63 and T69 of M41 S1 appear to be critical to
establish binding, and might therefore be located at the virus-host
interface.
Results and discussion
Previously, we have shown that recombinantly produced spike
S1 proteins of Beaudette lack the ability to bind chicken respiratory
tract tissue, in contrast to the M41 S1 protein. M41 when compared
to Beaudette has 26 amino acid differences in the S1 protein
(shown in Fig. 1A). One of these amino acid differences is located
in the signal sequence (position 14), while the others are scattered
throughout the mature S1 protein (aa 19–532). To elucidate the
amino acids important for binding of M41 S1 to the respiratory tract
we constructed chimeric S1 proteins by swapping coding regions
for the mature S1 protein of Beaudette with that of M41. At the
protein level, this resulted in introduction of the 15 most N-
terminal unique amino acids of M41 and the 10 most C-terminal
unique amino acids of M41 into Beaudette S1, resulting in respec-
tively MB.S1 and BM.S1 (Fig. 1B). Chimeric S1 and control M.S1 and
B.S1 proteins were produced in HEK293T cells and analyzed on
Western blot using Strep-Tactin. All S1 proteins were expressed and
appeared to be glycosylated to a similar extent (Fig. 1C). Spike
histochemistry revealed that MB.S1, but not BM.S1, had the ability
to bind to chicken trachea (Fig. 1D) and lung (Fig. 1E), indicating
that amino acids in the N-terminal part of M41 S1 are essential for
binding to chicken respiratory tract.
To pinpoint speciﬁc residues in M41 S1 that are important for
binding to chicken tissues, we next introduced fewer unique
amino acids of M41 into the Beaudette S1 background by swap-
ping smaller regions, resulting in MBB.S1 and BMB.S1, having the
ﬁrst 7 or second 8 unique amino acids of M41 respectively
(Fig. 2A). Again, soluble chimeric proteins were expressed and
appeared to be similar to M.S1 and B.S1 with respect to size and
glycosylation (results not shown). Spike histochemistry revealed
that only MBB, and not BMB, had the ability to bind to chicken
trachea (Fig. 2B), indicating that the M41 S1 region comprising aa
19–69 contains an important determinant for binding. Further
elucidation of particular S1 amino acids present at the interface
with the host cell surface focused on the single amino acids 19, 38,
43, 56, 63, 66 or 69, by individually introducing the M41 amino
acids at those positions into Beaudette S1 (expression cassettes
depicted in Fig. 2A). While all proteins were expressed, none of
them had the ability to bind to chicken respiratory tract tissues
(results not shown). Presumably, while gain of binding might
require more than one substitution, mutation of one critical amino
acid in M41 S1 would directly result in loss of binding, making it
easier to identify critical residues. We therefore decided to try the
reciprocal approach, by performing site-directed mutagenesis of
M41 S1 and introducing the particular amino acids of Beaudette at
each of those 7 positions individually (schematically depicted in
Fig. 2A). Indeed, spike histochemistry results showed that S1
mutants N38S, H43Q, P63S, and T69I lost their ability to bind to
the trachea (Fig. 2C), indicating that these amino acids are critical
for M41 spike attachment. Introducing these 4 amino acids of M41
into the Beaudette S1 background, however, did not result in
gain of binding (Fig. 2D). These results suggest that while these 4
amino acids are situated at the virus–host interface, the previously
identiﬁed residues A19, S56, and I66 also contribute to host
attachment. Of course, other amino acids present in these con-
structs that are identical between Beaudette and M41 also very
likely contribute to the binding of the spike.
Finally we aimed at identifying the minimal RBD of M41.
As folding is a major concern when generating truncated proteins,
we ﬁrst analyzed the predicted folding of the S1 protein. The S1
proteins of coronaviruses contain two domains that can fold
independently (Li 2012) and indeed, for IBV two such distinct
domains, separated by a short disordered domain, can be distin-
guished using FoldIndex (Fig. 3A). Sequences encoding these
domains, comprising residues 19-272 (M.NTD) and 273-532 (M.
CTD), were cloned and expressed in mammalian HEK293T cells
(Fig. 3B). Both truncated proteins could be isolated, indicating that
they indeed could fold independently. After PNGaseF treatment,
the NTD migrated according to the predicted 33 kDa of its back-
bone, while the CTD moved slightly slower than its expected
35 kDa (Fig. 3C). Both proteins are highly glycosylated, resulting in
migration patterns of around 60 and 55 kDa for NTD and CTD,
respectively. Since N-linked glycosylation adds 2.5 kDa of mole-
cular mass to a protein (Kornfeld and Kornfeld, 1985), this suggests
that all predicted N-glycosylation sites (8 and 5 in NTD and CTD,
respectively) may be used for glycosylation of these truncated
proteins. Spike histochemistry revealed that M.NTD, but not M.
CTD could bind to chicken respiratory tract, including trachea
(Fig. 3D) and lung (not shown). In addition, M.NTD is also
sufﬁcient to bind to other chicken tissues, in a similar manner as
M.S1, as exempliﬁed by staining of the oviduct (Fig. 3E). An
attempt to further truncate the minimal RBD was not successful
(data not shown), which might be due to the inability of smaller
domains to fold correctly or because multiple domains in the NTD
might be involved in binding to host tissues. The binding of NTD
appeared to be completely dependent on sialic acids, as binding
was lost upon pretreatment of the slides with VCNA to cleave off
sialic acids (Fig. 3F). No indication of binding to a protein (co)
receptor was observed, but it might be that downstream entry
events do require such (host speciﬁc) factor for productive infec-
tion. Sialic acid binding was previously observed for complete
M41 S1 (Wickramasinghe et al., 2011), and also recently for the
S1 of the nephropathogenic strain B1648 (Shahwan et al., 2013).
M.NTD preferred the same sugar substrate as complete M.S1
(Wickramasinghe et al., 2011), as binding to several Neu5Aca2-
3Gal-containing sugars was observed in glycan array (data not
shown). Taken together, our results show that the N-terminal 253
amino acids of M41 S1 are both required and sufﬁcient for binding
to host tissues, in an alpha-2,3-sialic acid-dependent way.
Sugar-binding has also been observed for several other cor-
onaviruses, including bovine coronavirus BCoV (Schultze et al.,
1991), human coronavirus HCoV-OC43 (Kunkel and Herrler, 1993),
and porcine coronavirus TGEV (Shahwan et al., 2013; Schultze
et al., 1996; Krempl et al., 1997). Of these, only the sugar-binding
domain of BCoV S1 has been mapped (Peng et al., 2012), and is like
that of IBV located in the NTD of S1. Interestingly, the only other
coronavirus in which the S1 NTD contains the RBD is murine
coronavirus MHV, with binding of a 330-amino acid domain (Kubo
et al., 1994) to the protein receptor CEACAM1a (Williams et al.,
1991; Dveksler et al., 1991). Crystal structures of the RBDs of BCoV
NTD (Peng et al., 2012) and MHV NTD (Peng et al., 2011) revealed
that both NTDs have structural topology similar to that of human
galactin. For IBV the tertiary structure of the NTD remains to be
determined, but it might well share a similar galactin fold as MHV
NTD and BCoV NTD, despite of their sequence diversity. Impor-
tantly, and in contrast to the sugar-binding coronaviruses BCoV
and HCoV-OC43, IBV does not have hemagglutinin–esterase activ-
ity to detach virus from sugars on host cells. This discrepancy, and
how IBV overcomes being trapped in the sialic acid-rich mucus
layer of the respiratory tract, is currently not understood.
Spike genes of IBV strains are highly diverse, with nucleotide
sequence identities in S1 ranging from 50% to 99%. The S1 gene, or
parts thereof, is therefore a common target for genotyping viral
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isolates (Lee et al., 2003; Wang and Huang, 2000; Jackwood et al.,
2005). In Fig. 4 an alignment of residues 19–69 of S1 proteins of
various IBV ﬁeld and vaccine strains is presented, showing con-
siderable difference in this entire region. However, the consensus
at position 38 and 43 are asparagine and histidine, respectively,
both amino acids that appear critical for attachment of M41.
The two other amino acids important for binding (P63 and T69)
are located in the previously recognized hypervariable region 1
(HVR1; residues 56–69 with numbering based on spike-coding
region including signal sequence; 34). HVR1 has been associated
with neutralization escape mutants (Cavanagh et al., 1988), and
variants of M41 that resisted neutralization had a substitution of
aa 63 from proline to histidine (selection variants) or serine (Beaud-
ette; 35). Sequence alignment shows that, in addition to Beaudette,
other strains that are passaged in embryonated eggs and are
derivatives of M41, including H52 and H120 (Bijlenga et al., 2004),
also have mutations at both positions 63 and 69. As Beaudette not
only has extended host tropism for mammalian cells (Fang et al.,
2005; Otsuki et al., 1979), but also lost its ability to cause disease in
chickens (Geilhausen et al., 1973), these amino acids in the spike
might contribute to determine host tropism and pathogenesis. The
consequences of the S1 sequence, including the RBD, on the outcome
of IBV infection has previously been suggested previously when
comparing the binding of M41 S1 with that of H120 and Beaudette to
chicken respiratory tract (Wickramasinghe et al., 2011). In particular,
the vaccine H120 and the non-virulent Beaudette strain had reduced
or no binding to chicken tissues, respectively, in agreement with the
reduced ability of these viruses to replicate in vivo. Also for other
coronaviruses the RBDs and neutralization determinants are often
located in the same domain (Mou et al., 2013; Du et al., 2013; Godet
et al., 1994; Liu et al., 2007; Breslin et al., 2003), stressing that key
spike–receptor interactions determine the outcome in vivo.
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Fig. 1. Recombinant chimeric IBV-S1 proteins. (A) Schematic representation of M41 spike protein (S1 region) in which the amino acids of M41 different from Beaudette S1
and their positions are indicated; amino acid residues of Beaudette are shown between brackets; (B) schematic representation of the chimeric S1 proteins. Amino acids
unique for M41 are in dark gray; light gray are amino acids similar between M41 and Beaudette, or unique for Beaudette. The S1 proteins are in frame with a GCN4 isoleucine
zipper trimerization motif (GCN4) and the Strep-tag II (ST); (C) S1 proteins expressed in HEK293T cells and puriﬁed from the culture media were analyzed by SDS-PAGE
followed by Western blot using Strep-Tactin; when indicated the samples were treated with PNGaseF prior to electrophoresis; (D/E) Spike histochemistry was performed by
incubating chicken trachea (D) and lung (E) tissues with Strep-Tactin-precomplexed IBV-S1 (5 μg) as described in Section 3.
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In conclusion, we mapped the minimal RBD of the IBV M41 to
the most N-terminal 19-272 residues of its spike protein. More-
over, we found that amino acids N38, H43, P63, and T69 appear to
be critical for binding of the spike to the chicken respiratory tract.
These data point toward important virus–host interactions ulti-
mately affecting the outcome of the infection in chickens.
Materials and methods
Cells
Human embryonic kidney (HEK) 293T cells were maintained in
Dulbecco's modiﬁed eagle medium (DMEM) (BioWhittaker) sup-
plemented with 2% glutamine, 10% fetal calf serum (FCS) (BioWhit-
taker) and 0.1 mg/ml gentamicin (Gibco Invitrogen).
Construction of expression plasmids
The expression vectors pCD5-M.S1 and pCD5-B.S1, encoding
codon-optimized S1 genes of M41 (M.S1; accession number
AY851295) or Beaudette (B.S1; accession number AJ311317) respec-
tively, preceded by the CD5 signal peptide and followed by a GCN4
trimerization motif and Strep-tag II were previously described
(Wickramasinghe et al., 2011). Constructs coding for chimeric S1
proteins were generated by splice overlap extension PCR on pCD5-
B.S1 and pCD5-M.S1 using the outer forward primer IBV-S1-
dom#1-FW (GTCGCTTCCGTGCTAGCA) and outer reversed primer
IBV-S1-dom#1 RV (ACTGACAGGCCAGCAGCT). Speciﬁc primers to
make chimeras and to introduce point mutations were generated
based upon codon-optimized sequences and sequences are avail-
able upon request. The resulting fragments were cloned using NheI
and BamHI into the pCD5 vector and the sequences were veriﬁed by
Fig. 2. Critical residues in M41 S1. (A) Schematic representation of the chimeric S1 proteins; the backbone of Beaudette and M41 are shown in light and dark gray,
respectively. Unique amino acids for M41 and Beaudette are depicted with dark and light gray boxes, respectively; (B) spike histochemistry of MBB and BMB on chicken
trachea tissue; (C/D) spike histochemistry of S1 mutant proteins containing single (C) or 4 (D) amino acid mutations.
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automated nucleotide sequencing. Constructs encoding the N-
terminal (NTD) or C-terminal (CTD) domain were generated after
verifying the predicted folding using FoldIndex (http://bip.weiz-
mann.ac.il/ﬂdbin/ﬁndex/) using primer set IBV-S1-dom#1 FW and
IBV-S1-RBdom#1 RV (GCGCTTAATTAATGGGAAGTTGTGCAGGGT)
and the set IBV-S1-RB#2 FW (CCGTGCTAGCAACATTTCATAATGA-
GACCGGAG) and IBV-S1-dom#3 RV (ATGGATCCGTACCCCTCAA),
respectively. Restriction sites NheI–PacI and NheI–BamHI (under-
lined) respectively were used to introduce these S1 domains
into pCD5.
Production and puriﬁcation of recombinant spike proteins
Spike proteins were produced from mammalian HEK293T cells
as described previously (Wickramasinghe et al., 2011). The super-
natants were harvested at 6 days post transfection, and the
proteins were puriﬁed using Strep-Tactin sepharose beads accor-
ding to the manufacturer's protocols (IBA GmbH). The protein
concentration was determined by Qubits 2.0 ﬂuorometer (Invi-
trogen) and their presence was conﬁrmed by Western blotting
using horseradish peroxidase (HRPO)-conjugated Strep-Tactin (IBA
GmbH). Where indicated, the spike proteins were treated with
N-glycosidase F (PNGase F; New England Biolabs Inc.) to remove
oligosaccharide side chains prior to electrophoresis according to
the manufacturer's procedures.
Spike histochemistry
Sections of formalin-ﬁxed, parafﬁn-embedded tissues from the
trachea and lung of a 6-week-old male broiler chicken were used to
study the binding of spike glycoproteins as described previously
(Wickramasinghe et al., 2011). Equimolar concentrations of chimeric
S1 spike proteins and M.NTD and M.CTD proteins were used, appl-
ying 100 μg/ml S1 and 60 μg/ml for M.NTD and M.CTD respectively
to each section. To study the dependence of the binding of protein
on sialic acids, tissue slides were pre-incubated with 1 mU Vibrio
cholera neuraminidase (VCNA; Roche) at 37 1C overnight, before
performing spike histochemistry.
Glycan array analysis
Ligand proﬁling of M.NTD was performed in a similar way as
previously reported for M.S1 (Wickramasinghe et al., 2011) using
printed slides of the CFG glycan library.
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